A	B	C
1	Main
2		Brand	Opzelura
3		Generic	ruxolitinib
4		Administrational	topical cream
5		Indication	Vitiligo. 1.5m vitiligo patients in the US.
6			Atopic dermatitis.
7		Regulatory	FDA approved 7/18/22
8		Economics	100% WW
9		Clinical Trials
10			Phase III "TRuE-V1" vitiligo
11			VASI PE: 30% had >75% improvement vs 8% in placebo
12
13			Phase III "TRuE-V2" vitiligo
14			VASI PE: 30% had >75% improvement vs 13% in placebo
15
16			Phase III "TRuE-CHE1" chronic hand eczema
17
18			Phase III "TRuE-CHE2" chronic hand eczema
19
20			Phase III "TRuE-AD3" pediatric eczema